Showing results (61-70 of 614) with videos related to
Sort By:
Pageof 62
Journal of Hypertension|January 1, 1990
Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinationsH R Brunner, J Ménard, B Waeber, et al.Kidney International|September 29, 2001
Renal and neurohormonal responses to increasing levels of lower body negative pressure in menG Würzner, A Chiolero, M Maillard, et al.Hypertension (Dallas, Tex. : 1979)|September 1, 1993
Salt-dependent renal effects of an angiotensin II antagonist in healthy subjectsM Burnier, B Rutschmann, J Nussberger, et al.Hypertension (Dallas, Tex. : 1979)|September 1, 1995
Postischemic blood flow response in hypercholesterolemic patientsD Hayoz, R Weber, B Rutschmann, et al.Clinical and Experimental Pharmacology & Physiology|March 4, 2000
Salt- and angiotensin II-dependent variations in amiloride-sensitive rectal potential difference in miceQ Wang, J D Horisberger, M Maillard, et al.American Journal of Hypertension|January 5, 2000
Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assayM P Maillard, L Mazzolai, V Daven, et al.Kidney International|May 31, 2001
Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous miceQ Wang, E Hummler, M Maillard, et al.Journal of Cardiovascular Pharmacology|March 10, 2000
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6M P Maillard, J Rossat, J Nussberger, et al.Journal of Hypertension|July 1, 1995
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertensionB Favrat, M Burnier, J Nussberger, et al.Journal of Cardiovascular Pharmacology|February 1, 1990
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibitionV Mooser, J Nussberger, L Juillerat, et al.Pageof 62